Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 6Recruiting 5Unknown 2Not yet recruiting 2Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Melanoma 12Carcinoma, Hepatocellular 11Carcinoma, Non-Small-Cell Lung 9Nasopharyngeal Carcinoma 8Esophageal Squamous Cell Carcinoma 8Stomach Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Colorectal Neoplasms 5Breast Neoplasms 5Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4Liver Neoplasms 4Carcinoma, Transitional Cell 4Triple Negative Breast Neoplasms 3Sarcoma 3Neoplasm Metastasis 3Lung Neoplasms 3Hypopharyngeal Neoplasms 3Cholangiocarcinoma 3Solid Tumor 2Recurrence 2Lymphoma 2Laryngeal Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2Advanced Solid Tumor 2Upper Tract Urinary Carcinoma 1Thyroid Neoplasms 1Thymic epithelial tumor 1

Interventions

spartalizumab 3Injections 3toripalimab 2camrelizumab 2anlotinib 2Therapeutics 2Cisplatin 2Capecitabine 2tislelizumab 1pembrolizumab 1fludarabine 1donafenib 1Pemetrexed 1PM 01183 1Leucovorin 1Irinotecan 1Injections, Intravenous 1Gemcitabine 1Fluorouracil 1Cyclophosphamide 1Carboplatin 15'-Nucleotidase 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Advanced Solid Tumor × toripalimab × Clear all
NCT06410703 2024-10-31

CAN1012 Combined With PD-1 in Patients With Solid Tumors

Canwell Biotech Limited

Phase 1/2 Unknown
71 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT04337463 2021-05-17

ATG-008 Combined With Toripalimab in Advanced Solid Tumors

Sichuan University

Phase 1/2 Unknown
60 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡